Department of Computer Science, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA.
Center On the Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Clin Epigenetics. 2021 Mar 4;13(1):47. doi: 10.1186/s13148-021-01032-6.
Maternal smoking affects more than half a million pregnancies each year in the US and is known to result in fetal growth restriction as measured by lower birthweight and its associated long-term consequences. Maternal smoking also has been linked to altered fetal DNA methylation (DNAm). However, what remains largely unexplored is whether these DNAm alterations are merely markers of smoking exposure or if they also have implications for health outcomes. This study tested the hypothesis that fetal DNAm mediates the effect of maternal smoking on newborn birthweight.
This study included mother-newborn pairs from a US predominantly urban, low-income multi-ethnic birth cohort. DNAm in cord blood were determined using the Illumina Infinium MethylationEPIC BeadChip. After standard quality control and normalization procedures, an epigenome-wide association study (EWAS) of maternal smoking was performed using linear regression models, controlling for maternal age, education, race, parity, pre-pregnancy body mass index, alcohol consumption, gestational age, maternal pregestational/gestational diabetes, child sex, cord blood cell compositions and batch effects. To quantify the degree to which cord DNAm mediates the smoking-birthweight association, the VanderWeele-Vansteelandt approach for single mediator and structural equational model for multiple mediators were used, adjusting for pertinent covariates.
The study included 954 mother-newborn pairs. Among mothers, 165 (17.3%) ever smoked before or during pregnancy. Newborns with smoking exposure had on average 258 g lower birthweight than newborns without exposure (P < 0.001). Using a false discovery rate (FDR) < 0.05 as the significance cutoff, the EWAS identified 38 differentially methylated CpG sites associated with maternal smoking. Of those, 17 CpG sites were mapped to previously reported genes: GFI1, AHRR, CYP1A1, and CNTNAP2; 8 of those, located in the first three genes, were Bonferroni significantly associated with newborn birthweight and mediated the smoking-birthweight association. The combined mediation effect of the three genes explained 67.8% of the smoking-birthweight association.
Our study not only lends further support that maternal smoking alters fetal DNAm in a multiethnic population, but also suggests that fetal DNAm substantially mediates the maternal smoking-birthweight association. Our findings, if further validated, indicate that DNAm modification is likely an important pathway by which maternal smoking impairs fetal growth and, perhaps, even long-term health outcomes.
在美国,每年有超过 50 万例妊娠受到母亲吸烟的影响,这被认为会导致胎儿生长受限,表现为出生体重降低及其相关的长期后果。母亲吸烟也与胎儿 DNA 甲基化(DNAm)的改变有关。然而,目前仍有很大一部分尚未得到探索的是,这些 DNAm 改变仅仅是吸烟暴露的标志物,还是它们也对健康结果有影响。本研究检验了以下假设,即胎儿 DNAm 介导了母亲吸烟对新生儿出生体重的影响。
本研究纳入了来自美国一个以城市为主、以低社会经济地位的多民族出生队列的母亲-新生儿对子。使用 Illumina Infinium MethylationEPIC BeadChip 测定脐带血中的 DNAm。在经过标准质量控制和标准化程序后,使用线性回归模型对母亲吸烟进行了全基因组关联研究(EWAS),模型控制了母亲的年龄、教育程度、种族、产次、孕前/孕时体重指数、饮酒量、胎龄、母亲孕前/妊娠期糖尿病、儿童性别、脐带血细胞组成和批次效应。为了量化脐带 DNAm 对吸烟-出生体重关联的介导程度,使用了单一中介物的 VanderWeele-Vansteelandt 方法和多个中介物的结构等式模型,同时调整了相关协变量。
本研究纳入了 954 对母亲-新生儿对子。在母亲中,有 165 人(17.3%)在孕前或孕期有过吸烟史。有吸烟暴露的新生儿的出生体重平均比没有暴露的新生儿低 258 克(P<0.001)。使用错误发现率(FDR)<0.05 作为显著性截断值,EWAS 鉴定出 38 个与母亲吸烟相关的差异甲基化 CpG 位点。其中,17 个 CpG 位点映射到先前报道的基因上:GFI1、AHRR、CYP1A1 和 CNTNAP2;位于前三个基因中的 8 个 CpG 位点与新生儿出生体重呈 Bonferroni 显著相关,并介导了吸烟-出生体重关联。这三个基因的综合中介效应解释了 67.8%的吸烟-出生体重关联。
本研究不仅进一步支持了母亲吸烟在多民族人群中改变胎儿 DNAm,而且还表明胎儿 DNAm 很大程度上介导了母亲吸烟与新生儿出生体重之间的关联。如果进一步得到验证,我们的发现表明,DNAm 修饰可能是母亲吸烟损害胎儿生长乃至长期健康结果的一个重要途径。